List view / Grid view
FPS Food and Pharma Systems is a leading company in the pharmaceutical and fine chemical fields, developing, manufacturing and installing worldwide its own range of fine size reduction machines and containment solutions (sterile and highly toxic API)...
The FDA has prioritised the review of this drug application after multiple recalls of generic valsartan products from several manufacturers...
Pharmaceutical and biotechnology patent applications increased by 13 percent last year, with over 6,000 applications coming from European companies...
A project backed by major pharma will advance the Lab of the Future with proof of concept software to digitise experiment methods…
Forum LABO PARIS has revealed the nominees in the 2019 Innovation Awards, which reward the exhibitors’ know-how and the most outstanding new products...
Watson-Marlow Fluid Technology Group has partnered with Interphex to promote safer, more reliable bioprocessing....
The goal is to improve manufacturing flexibility, enhance quality and uniformity, while lowering the costs for patients...
The Italian Biochemical Institute, Comecer, and Particle Measuring Systems share expertise to develop and manufacture a safer intravenous solution...
Colour-coded generics might help consumers differentiate between generics and branded medicines...
Researchers have identified a possible association between use of statins and developing type 2 diabetes after following patients for 15 years...
Scott Gottlieb has announced that he will resign from the position of commissioner of the US Food and Drug Administration (FDA) at the end of the month...
The EMA has announced that fees for new drug applications will be different from the beginning of April 2019, taking into account the rate of inflation...
The generic version will cost 50 percent less that the current Humalog list price...
The pharmaceutical drug delivery market could reach $1,694.7 billion by 2023, increasing at a CAGR of 6.4 percent during the period...
FDA is 'deeply concerned' about a third type of nitrosamine impurity detected in angiotensin II receptor blocker (ARB) medicines...
